OLMA (Olema Pharmaceuticals) Buyback Yield %: -4.23 (As of Jun. 30, 2026)


OLMA Olema Pharmaceuticals inc OLMA
33 GF Score
Price $12.22
! 2 Warning Signs
View Full Analysis

What is Olema Pharmaceuticals Buyback Yield %?

Olema Pharmaceuticals OLMA +7.49% 33 Buyback Yield % is -4.23 as of Jun. 30, 2026. GuruFocus rates OLMA with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 742 Biotechnology companies, Olema Pharmaceuticals ranks better than 61.59% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Olema Pharmaceuticals's current buyback yield was -4.23%.

Olema Pharmaceuticals Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Olema Pharmaceuticals's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olema Pharmaceuticals Buyback Yield % Chart

Olema Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial 0.00 0.00 -16.81 -61.46 -10.10

Olema Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.57 -83.29 -36.23 -10.10 -3.22

OLMA vs DRTS, ORIC, KURA: Buyback Yield % Comparison

For the Biotechnology subindustry, Olema Pharmaceuticals's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Olema Pharmaceuticals Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Olema Pharmaceuticals's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Olema Pharmaceuticals's Buyback Yield % falls into.


OLMA
33GF Score
Olema Pharmaceuticals inc OLMA
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olema Pharmaceuticals Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Olema Pharmaceuticals's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 205.39) / 2034.4
=-10.10%

Olema Pharmaceuticals's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 41.918) / 1302.13503
=-3.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -4.23 mean?
Olema Pharmaceuticals (OLMA) has a Buyback Yield % of -4.23 as of Jun. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Olema Pharmaceuticals and its competitors. According to the industry distribution chart, Olema Pharmaceuticals ranks #285 out of 742 companies in the Biotechnology industry, placing it in the top 38.4%.
Is Olema Pharmaceuticals' Buyback Yield % too high?
Olema Pharmaceuticals' current Buyback Yield % is -4.23. Based on the distribution chart, Olema Pharmaceuticals ranks #285 out of 742 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Olema Pharmaceuticals has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Olema Pharmaceuticals' Buyback Yield % compare to DRTS and ORIC?
According to the Biotechnology industry distribution chart, Olema Pharmaceuticals ranks #285 out of 742 companies for Buyback Yield %. This puts Olema Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Olema Pharmaceuticals and its competitors. Olema Pharmaceuticals's current Buyback Yield % is -4.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olema Pharmaceuticals stock overvalued right now?
Olema Pharmaceuticals (OLMA) has a current Buyback Yield % of -4.23. The current Buyback Yield % is -4.23. Olema Pharmaceuticals' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Olema Pharmaceuticals (OLMA), the current Buyback Yield % is -4.23 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Olema Pharmaceuticals Business Description

Address 780 Brannan Street, San Francisco, CA, USA, 94103
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
33GF Score

Get the complete analysis for OLMA

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.22
Price